A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease.
Wraith
D C
DC
Cambridge University Department of Pathology, UK.
Smilek
D E
DE
D000595:Amino Acid Sequence; D000818:Animals; D001324:Autoantigens / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D001667:Binding, Competitive; D004195:Disease Models, Animal; D000949:Histocompatibility Antigens Class II / Q000276:immunology* / Q000378:metabolism; D007167:Immunotherapy / Q000379:methods*; D008969:Molecular Sequence Data; D010455:Peptides / Q000378:metabolism / Q000627:therapeutic use; D011485:Protein Binding; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*
D001324:Autoantigens; D000949:Histocompatibility Antigens Class II; D010455:Peptides; D011948:Receptors, Antigen, T-Cell